Lansen Pharmaceutical Holdings Limited (0503.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap79.06M
Enterprise Value46.33M
P/E Ratio11.18
PEG Ratio0.11
Price/Sales Ratio1.46
Price/Book Ratio0.79
Enterprise/Revenue0.96
Enterprise/EBITDA4.13

Fiscal Year

Fiscal YearDecember 31, 2022
Most Recent QuarterJune 30, 2023

Profitability

Profit Margin0.13
Operating Margin0.22
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue65.56M
Revenue/Share0.16
Gross Profit44.3M
EBITDA15.26M
Net Income8.6M
Diluted EPS0.02

Balance Sheet

Total Cash46.39M
Total Cash/Share0.12
Total Debt17.76M
Total Debt/Equity0.15
Current Ratio2.21
Book Value Per Share0.29

Price History

52-Week Change23.58
52-Week High1.82
52-Week Low1.2
Moving Average 50 Days1.72
Moving Average 200 Days1.55

Statistics

Average Volume476,561
Shares Outstanding419.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor517781:500000
Last Split DateApril 11, 2023
AD